Post-discharge Glycemic Control After Liver Transplant and Impact on Transplant Outcomes
Icahn School of Medicine at Mount Sinai
Summary
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Description
Liver transplant participants will be recruited. Participants will wear a blinded sensor after hospital discharge for up to 30 days. Data can be shared with participant and the providers retrospectively. Participants will be invited to wear another blinded sensor at 6 and 12 months.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL Exclusion Criteria: * having a planned discharge to a rehabilitation or nursing facility, * a contraindication to sensor placement, * if discharge is anticipated to be \>30 days post-transplant, or * if recent transplant also included a kidney or pancreas transplant
Interventions
- DeviceLibre 3+
Blinded CGM will be worn by all participants
Location
- Mount Sinai HospitalNew York, New York